Market News & Trends
Dyax Announces $30 Million Offering
Dyax Corp. recently announced it has priced a registered direct offering with RA Capital Management, Venrock, Federated Investors, Inc. and one other institutional investor for…
AmerisourceBergen Corporation Completes $308-Million Divestiture
Frazier Healthcare and Packaging Coordinators, Inc. recently announced it has completed the acquisition of pharmaceutical packager AndersonBrecon from its parent company AmerisourceBergen Corporation. AndersonBrecon will…
Theravance & Elan Sign $1-Billion Agreement
Theravance, Inc. and Elan Corporation, plc recently announced they have entered into a royalty participation agreement wherein Elan will purchase a participation interest in potential…
Arbor Pharmaceuticals Announces FDA Approval
Arbor Pharmaceuticals recently announced that the US FDA has approved its New Drug Application (NDA) for Nymalize (nimodipine) oral solution. Nymalize was previously granted Orphan…
Andain Announces Innovative Organ-Targeted Drug Delivery Nanoparticles
Andain Inc. recently announced its innovative nanoparticles drug delivery technology. Andain completed the development of innovative lipid-based drug delivery nanoparticles capable of carrying hydrophilic and…
Sagent Pharma to Acquire Remaining Interest in Company for $25 Million
Sagent Pharmaceuticals, Inc. recently announced an agreement to acquire the 50% interest of its joint venture partner, Chengdu Kanghong Pharmaceuticals (Group) Co. Ltd. formerly Chengdu…
Concert Pharmaceuticals & Celgene Sign $300-Million Tech Deal
Concert Pharmaceuticals, Inc. recently announced it has entered into a strategic collaboration with Celgene Corporation directed toward deuterium-modified compounds targeting cancer and inflammation. The collaboration…
Astellas Pharma & Drais Pharmaceuticals to Launch Virtual Co.
Astellas Pharma Inc. and Drais Pharmaceuticals, Inc.recently announced they have entered into a third partnership in the past year to develop and commercialize an Astellas…
Arena Pharmaceuticals Receives $65 Million From Eisai
Arena Pharmaceuticals, Inc. recently announced that the Office of the Federal Register filed for public inspection the US Drug Enforcement Administration's (DEA) final rule placing…
Recipharm & Synthonics Join Forces to Promote Delivery Technology
Recipharm Pharmaceutical Development AB and Synthonics, Inc. recently announced the formation of a Joint Promotion Agreement. The contract, the first of its kind to be…
Actavis Buys Antibiotic Vaginal Gel for $55 Million
Actavis, Inc. and Valeant Pharmaceuticals International, Inc. recently announced that Actavis Specialty Brands has acquired worldwide rights to Valeant's Metronidazole 1.3% Vaginal Gel antibiotic development…
FORMA Therapeutics Strikes $200-Million Deal
FORMA Therapeutics Holdings, recently announced a strategic collaboration agreement with Celgene Corporation under which FORMA and Celgene will discover, develop, and commercialize drug candidates to…
Imugene Granted Patent for Novel Delivery Technology
Australian drug delivery technology company Imugene recently announced the acceptance of a key Chinese patent application for the company’s novel drug delivery technology Linguet (Patent…
PAREXEL International Acquires HERON Group
PAREXEL International Corporation recently announced it has acquired all of the outstanding equity securities of the HERON Group LTD, a life sciences consultancy that provides…
Pharma & Biotech Industries Headed Toward an Era of Reduced Profit Margins
In the face of reduced profit margins for the pharmaceutical and biotechnology sectors, an effective financial management strategy is central to maintain sustainable growth. New…
Revolutionary Autoinjector Pushes the Limits of High-Viscosity Drug Delivery
Oval Medical Technologies Ltd recently announced that a variety of 1100 cPs solutions (the thickness of motor oil) have been successfully delivered through a 25-G…
BIND Therapeutics & AstraZeneca Announce Lucrative Worldwide Agreement
BIND Therapeutics and AstraZeneca recently announced it has entered into a strategic collaboration to develop and commercialize an Accurin, a targeted and programmable cancer nanomedicine…
Elite Pharmaceuticals Secures $10 Million Funding
Elite Pharmaceuticals, Inc. recently announced it has entered into a $10 million common stock purchase agreement with Lincoln Park Capital Fund, LLC, a Chicago-based institutional…
FDA Gives Breakthrough Designation to Merck Drug
Merck recently announced the US Food and Drug Administration (FDA) has designated lambrolizumab (MK-3475) as a Breakthrough Therapy for the treatment of patients with advanced…
GSK & Avalon to Form Up to 10 Biotechs in San Diego
GlaxoSmithKline PLC recently announced it will partner with venture capitalists from San Diego in an unusual deal worth up to $495 million to start several…
